{"entity":{"type":"insider","cik":"0001675217","url":"/insider/0001675217","json_url":"/insider/0001675217.json","name":"Vifor (International) Ltd","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":67,"n_filings":9,"first":"2020-07-07","last":"2021-10-13","span_basis":"filed_date"},"name_variants":[{"name":"Vifor (International) Ltd","source":"filing","n_filings":9,"first_seen":"2020-07-07","last_seen":"2021-10-13"}],"transactions":[{"id":5238017,"accession":"0000899243-21-040141","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-040141","line_url":"/filing/0000899243-21-040141#line-1","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":null,"owner_name":"Vifor Fresenius Medical Care Renal Pharma Ltd.; Vifor (International) Ltd; Vifor Pharma Ltd.","owner_display_name":"Vifor Fresenius Medical Care Renal Pharma Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000000.0,"shares_display":"4,000,000","price_per_share":39.43,"price_display":"39.43","price_state":"stated","total_value":157720000.0,"total_display":"157,720,000.00","total_whole":"157,720,000","shares_owned_after":5194085.0,"shares_owned_after_display":"5,194,085","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-12","filed_date":"2021-10-13","scope":"insider"},{"id":2773281,"accession":"0000899243-20-021031","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-20-021031","line_url":"/filing/0000899243-20-021031","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":null,"owner_name":"Vifor Pharma Ltd.; Vifor (International) Ltd; Vifor Fresenius Medical Care Renal Pharma Ltd.","owner_display_name":"Vifor Pharma Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49258.0,"shares_display":"49,258","price_per_share":53.93347431077186,"price_display":"53.93","price_state":"stated","total_value":2656655.0776,"total_display":"2,656,655.08","total_whole":"2,656,655","shares_owned_after":9210735.0,"shares_owned_after_display":"9,210,735","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-03","filed_date":"2020-08-03","scope":"insider","n_lines":3},{"id":2773268,"accession":"0000899243-20-021031","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-20-021031","line_url":"/filing/0000899243-20-021031","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":null,"owner_name":"Vifor Pharma Ltd.; Vifor (International) Ltd; Vifor Fresenius Medical Care Renal Pharma Ltd.","owner_display_name":"Vifor Pharma Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40402.0,"shares_display":"40,402","price_per_share":52.394052764714615,"price_display":"52.39","price_state":"stated","total_value":2116824.5198,"total_display":"2,116,824.52","total_whole":"2,116,825","shares_owned_after":9244037.0,"shares_owned_after_display":"9,244,037","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-31","filed_date":"2020-08-03","scope":"insider","n_lines":3},{"id":2773247,"accession":"0000899243-20-021031","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-021031","line_url":"/filing/0000899243-20-021031","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":null,"owner_name":"Vifor Pharma Ltd.; Vifor (International) Ltd; Vifor Fresenius Medical Care Renal Pharma Ltd.","owner_display_name":"Vifor Pharma Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48081.0,"shares_display":"48,081","price_per_share":54.602235577463034,"price_display":"54.60","price_state":"stated","total_value":2625330.0888,"total_display":"2,625,330.09","total_whole":"2,625,330","shares_owned_after":9306212.0,"shares_owned_after_display":"9,306,212","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-30","filed_date":"2020-08-03","scope":"insider","n_lines":3},{"id":2456592,"accession":"0000899243-20-020673","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-20-020673","line_url":"/filing/0000899243-20-020673","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":null,"owner_name":"Vifor Fresenius Medical Care Renal Pharma Ltd.; Vifor Pharma Ltd.; Vifor (International) Ltd","owner_display_name":"Vifor Fresenius Medical Care Renal Pharma Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":88012.0,"shares_display":"88,012","price_per_share":52.57782209698677,"price_display":"52.58","price_state":"stated","total_value":4627479.2784,"total_display":"4,627,479.28","total_whole":"4,627,479","shares_owned_after":9334189.0,"shares_owned_after_display":"9,334,189","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-29","filed_date":"2020-07-29","scope":"insider","n_lines":3},{"id":2456569,"accession":"0000899243-20-020673","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-020673","line_url":"/filing/0000899243-20-020673","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":null,"owner_name":"Vifor Fresenius Medical Care Renal Pharma Ltd.; Vifor Pharma Ltd.; Vifor (International) Ltd","owner_display_name":"Vifor Fresenius Medical Care Renal Pharma Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40160.0,"shares_display":"40,160","price_per_share":53.51386907370518,"price_display":"53.51","price_state":"stated","total_value":2149116.982,"total_display":"2,149,116.98","total_whole":"2,149,117","shares_owned_after":9426628.0,"shares_owned_after_display":"9,426,628","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-28","filed_date":"2020-07-29","scope":"insider","n_lines":2},{"id":2456551,"accession":"0000899243-20-020673","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-020673","line_url":"/filing/0000899243-20-020673","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":null,"owner_name":"Vifor Fresenius Medical Care Renal Pharma Ltd.; Vifor Pharma Ltd.; Vifor (International) Ltd","owner_display_name":"Vifor Fresenius Medical Care Renal Pharma Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34236.0,"shares_display":"34,236","price_per_share":53.3203516240215,"price_display":"53.32","price_state":"stated","total_value":1825475.5582,"total_display":"1,825,475.56","total_whole":"1,825,476","shares_owned_after":9470788.0,"shares_owned_after_display":"9,470,788","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-27","filed_date":"2020-07-29","scope":"insider","n_lines":2},{"id":2632737,"accession":"0000899243-20-020448","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-20-020448","line_url":"/filing/0000899243-20-020448","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":null,"owner_name":"Vifor Fresenius Medical Care Renal Pharma Ltd.; Vifor (International) Ltd; Vifor Pharma Ltd.","owner_display_name":"Vifor Fresenius Medical Care Renal Pharma Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26050.0,"shares_display":"26,050","price_per_share":52.54267282533589,"price_display":"52.54","price_state":"stated","total_value":1368736.6271,"total_display":"1,368,736.63","total_whole":"1,368,737","shares_owned_after":9504595.0,"shares_owned_after_display":"9,504,595","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-24","filed_date":"2020-07-24","scope":"insider","n_lines":3},{"id":2632723,"accession":"0000899243-20-020448","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-20-020448","line_url":"/filing/0000899243-20-020448","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":null,"owner_name":"Vifor Fresenius Medical Care Renal Pharma Ltd.; Vifor (International) Ltd; Vifor Pharma Ltd.","owner_display_name":"Vifor Fresenius Medical Care Renal Pharma Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34555.0,"shares_display":"34,555","price_per_share":54.15414677181305,"price_display":"54.15","price_state":"stated","total_value":1871296.5417,"total_display":"1,871,296.54","total_whole":"1,871,297","shares_owned_after":9532691.0,"shares_owned_after_display":"9,532,691","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-23","filed_date":"2020-07-24","scope":"insider","n_lines":4},{"id":2632701,"accession":"0000899243-20-020448","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-020448","line_url":"/filing/0000899243-20-020448","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":null,"owner_name":"Vifor Fresenius Medical Care Renal Pharma Ltd.; Vifor (International) Ltd; Vifor Pharma Ltd.","owner_display_name":"Vifor Fresenius Medical Care Renal Pharma Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72469.0,"shares_display":"72,469","price_per_share":55.5805706274407,"price_display":"55.58","price_state":"stated","total_value":4027868.3728,"total_display":"4,027,868.37","total_whole":"4,027,868","shares_owned_after":9578280.0,"shares_owned_after_display":"9,578,280","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-22","filed_date":"2020-07-24","scope":"insider","n_lines":2},{"id":2245174,"accession":"0000899243-20-019818","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-20-019818","line_url":"/filing/0000899243-20-019818","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":null,"owner_name":"Vifor Fresenius Medical Care Renal Pharma Ltd.; Vifor Pharma Ltd.; Vifor (International) Ltd","owner_display_name":"Vifor Fresenius Medical Care Renal Pharma Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":87529.0,"shares_display":"87,529","price_per_share":55.49740154691588,"price_display":"55.50","price_state":"stated","total_value":4857632.06,"total_display":"4,857,632.06","total_whole":"4,857,632","shares_owned_after":9633571.0,"shares_owned_after_display":"9,633,571","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-21","filed_date":"2020-07-21","scope":"insider","n_lines":2},{"id":2245166,"accession":"0000899243-20-019818","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-20-019818","line_url":"/filing/0000899243-20-019818","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":null,"owner_name":"Vifor Fresenius Medical Care Renal Pharma Ltd.; Vifor Pharma Ltd.; Vifor (International) Ltd","owner_display_name":"Vifor Fresenius Medical Care Renal Pharma Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54598.0,"shares_display":"54,598","price_per_share":56.02866849701454,"price_display":"56.03","price_state":"stated","total_value":3059053.2426,"total_display":"3,059,053.24","total_whole":"3,059,053","shares_owned_after":9714837.0,"shares_owned_after_display":"9,714,837","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-20","filed_date":"2020-07-21","scope":"insider","n_lines":2},{"id":2245156,"accession":"0000899243-20-019818","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-019818","line_url":"/filing/0000899243-20-019818","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":null,"owner_name":"Vifor Fresenius Medical Care Renal Pharma Ltd.; Vifor Pharma Ltd.; Vifor (International) Ltd","owner_display_name":"Vifor Fresenius Medical Care Renal Pharma Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47890.0,"shares_display":"47,890","price_per_share":55.85937543746085,"price_display":"55.86","price_state":"stated","total_value":2675105.4897,"total_display":"2,675,105.49","total_whole":"2,675,105","shares_owned_after":9791748.0,"shares_owned_after_display":"9,791,748","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-17","filed_date":"2020-07-21","scope":"insider","n_lines":3},{"id":2328947,"accession":"0000899243-20-019424","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-20-019424","line_url":"/filing/0000899243-20-019424","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":null,"owner_name":"Vifor Pharma Ltd.; Vifor (International) Ltd; Vifor Fresenius Medical Care Renal Pharma Ltd.","owner_display_name":"Vifor Pharma Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":73500.0,"shares_display":"73,500","price_per_share":56.96245972789116,"price_display":"56.96","price_state":"stated","total_value":4186740.79,"total_display":"4,186,740.79","total_whole":"4,186,741","shares_owned_after":9863485.0,"shares_owned_after_display":"9,863,485","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-16","filed_date":"2020-07-16","scope":"insider","n_lines":4},{"id":2328927,"accession":"0000899243-20-019424","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-20-019424","line_url":"/filing/0000899243-20-019424","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":null,"owner_name":"Vifor Pharma Ltd.; Vifor (International) Ltd; Vifor Fresenius Medical Care Renal Pharma Ltd.","owner_display_name":"Vifor Pharma Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":86298.0,"shares_display":"86,298","price_per_share":59.22467834596399,"price_display":"59.22","price_state":"stated","total_value":5110971.2919,"total_display":"5,110,971.29","total_whole":"5,110,971","shares_owned_after":9890825.0,"shares_owned_after_display":"9,890,825","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-15","filed_date":"2020-07-16","scope":"insider","n_lines":2},{"id":2328919,"accession":"0000899243-20-019424","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-019424","line_url":"/filing/0000899243-20-019424","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":null,"owner_name":"Vifor Pharma Ltd.; Vifor (International) Ltd; Vifor Fresenius Medical Care Renal Pharma Ltd.","owner_display_name":"Vifor Pharma Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":58.083177435,"price_display":"58.08","price_state":"stated","total_value":5808317.7435,"total_display":"5,808,317.74","total_whole":"5,808,318","shares_owned_after":9995364.0,"shares_owned_after_display":"9,995,364","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-14","filed_date":"2020-07-16","scope":"insider","n_lines":3},{"id":3111749,"accession":"0000899243-20-019014","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000899243-20-019014","line_url":"/filing/0000899243-20-019014","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":null,"owner_name":"Vifor Fresenius Medical Care Renal Pharma Ltd.; Vifor Pharma Ltd.; Vifor (International) Ltd","owner_display_name":"Vifor Fresenius Medical Care Renal Pharma Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":58.150271668,"price_display":"58.15","price_state":"stated","total_value":5815027.1668,"total_display":"5,815,027.17","total_whole":"5,815,027","shares_owned_after":10135831.0,"shares_owned_after_display":"10,135,831","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-13","filed_date":"2020-07-13","scope":"insider","n_lines":5},{"id":3111718,"accession":"0000899243-20-019014","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-20-019014","line_url":"/filing/0000899243-20-019014","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":null,"owner_name":"Vifor Fresenius Medical Care Renal Pharma Ltd.; Vifor Pharma Ltd.; Vifor (International) Ltd","owner_display_name":"Vifor Fresenius Medical Care Renal Pharma Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45844.0,"shares_display":"45,844","price_per_share":59.924350331559204,"price_display":"59.92","price_state":"stated","total_value":2747171.9166,"total_display":"2,747,171.92","total_whole":"2,747,172","shares_owned_after":10178028.0,"shares_owned_after_display":"10,178,028","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-10","filed_date":"2020-07-13","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":"2020-07-10|3111699","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001340652","name":"ChemoCentryx, Inc.","url":"/issuer/0001340652","role":"Ten percent owner","n_filings":9,"first_seen":"2020-07-07","last_seen":"2021-10-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001675217","retrieved_at":"2026-08-22T13:35:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}